NS
TAK icon

NBC Securities’s Takeda Pharmaceutical TAK Stock Holding History

NBC Securities’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$880K Sell
47,533
-6,876
-13% -$121K 0.07% 312
2025
Q4 		$848K Sell
54,409
-49
-0.1% -$701 0.06% 318
2025
Q3 		$797K Sell
54,458
-988
-2% -$14.7K 0.06% 340
2025
Q2 		$857K Sell
55,446
-206
-0.4% -$3.04K 0.07% 308
2025
Q1 		$827K Buy
55,652
+55,601
+109,022% +$779K 0.07% 291
2024
Q4 		$682 Sell
51
-51,768
-100% -$711K 0.06% 338
2024
Q3 		$736K Buy
51,819
+105
+0.2% +$1.49K 0.06% 337
2024
Q2 		$669K Buy
51,714
+8,175
+19% +$108K 0.06% 340
2024
Q1 		$614K Buy
43,539
+765
+2% +$11.1K 0.06% 379
2023
Q4 		$610K Buy
42,774
+1,440
+3% +$20.4K 0.06% 345
2023
Q3 		$639K Buy
+41,334
New +$640K 0.07% 303

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return